WALTHAM, Mass.--(BUSINESS WIRE)--May 31, 2012-- N-of-One, Inc., provider of Diagnostic Strategy Roadmaps(TM) and Treatment Strategy Roadmaps(TM) for personalized cancer care, announced today the appointment of Christine Cournoyer as the company's Chief Executive Officer. Ms. Cournoyer brings to N-of-One more than 25 years of executive leadership experience with healthcare technology companies, including her position as President and Chief Operating Officer of Picis, a provider of health information software solutions installed in more than 1,800 medical centers and hospital systems worldwide prior to its acquisition by United Healthcare in 2010.

Jennifer Levin Carter, MD, MPH, the company's founder and President, will remain President and has taken on additional responsibility as Chief Medical Officer, an expanded role to lead further product development of N-of-One's diagnostic and treatment strategy roadmaps for wider use by healthcare providers and other collaborators.

"Over the past four years, we've helped hundreds of cancer patients access our diagnostic and treatment strategy roadmaps as we developed and systematized our PrecisionWorks(TM) platform," said Dr. Carter.

"N-of-One is now positioned to scale this platform to power oncologists, regional cancer centers, and provider networks anywhere with leading-edge, data-driven knowledge and decision-support tools.

We are extremely pleased that Chris, a distinguished and proven leader in the healthcare IT industry, was attracted to the vast potential of N-of-One to help transform oncology care, and we have great confidence in her ability to lead the company into its next phase of growth." "We are very fortunate to have Chris join the N-of-One team at this important stage in the company's development," said Joseph O'Connor, a member of N-of-One's Board of Directors. "Chris is an ideal leader with a successful track record of delivering valuable clinical information technology solutions to the provider market. Her deep experience working with large healthcare networks will be a critical factor in realizing N-of-One's growth strategy. N-of-One is well positioned in the exciting field of personalized medicine due to the significant efforts of Jennifer and the talented N-of-One team. We will benefit immensely from Jennifer's continued thought leadership and ability to envision new ways to enhance healthcare delivery through the use of more precise clinical knowledge." "We're living in a time of unprecedented opportunity to transform cancer treatment and outcomes," said Ms. Cournoyer. "For the first time, we have the knowledge and capabilities not only to identify genetic disruptions in an individual patient's tumor cells that may be molecular drivers of that person's unique cancer, but to match the results of this patient-specific tumor profile to precise knowledge, diagnostic tools, and treatments that target the molecular underpinnings of each patient's specific disease. It is a great privilege to have been asked to lead N-of-One as the company prepares to scale its successful precision oncology platform for wider use by regional cancer centers and provider networks that are competing for share in the fast-growing and increasingly competitive oncology market." Prior to joining N-of-One, Christine Cournoyer was President and Chief Operating Officer of Picis (now a division of United Healthcare), a leading company in the healthcare IT market offering software solutions that bridge revenue cycle and clinical workflow management for the high-acuity operations of hospitals (emergency rooms, operating rooms, and critical care). Under Ms. Cournoyer's leadership, Picis' revenues and profits more than doubled in five years, resulting in its sale to United Healthcare in 2010. At the time of its acquisition, Picis' systems were installed in more than 1,800 medical centers, hospitals, and integrated delivery networks in 19 countries around the world. Prior to joining Picis, Ms. Cournoyer was Managing Director of Harte-Hanks, a database and analytics marketing company.

She also served as President and Chief Operating Officer of Lightbridge, Inc. and held senior management positions at IBM, including Vice President of Business Transformation and Chief Information Officer of IBM's software group; and she formerly served as Senior Vice President at Lotus Development. Ms. Cournoyer was named one of the "10 Most Influential Women in Technology" by Businessweek magazine and one of Boston Magazine's "Top 100 Women Who Run This Town." She served on the boards of the Stride Rite Corporation, GTECH, and BJ's Wholesale Club during the period that BJ's was taken private.

She is currently a Corporator for Emerson Hospital and a member of the Boston Club and the Women Corporate Directors. Ms. Cournoyer earned a B.S. from UMass, Lowell and an MA in Economics from Northeastern University. She also attended Massachusetts Institute of Technology's Executive Education Program.

Jennifer Levin Carter, MD, MPH, founded N-of-One in 2008 and currently serves as President and Chief Medical Officer. A board-certified internist and seasoned entrepreneur, she has more than 20 years of experience evaluating existing and emerging markets, new medical technologies, and early-stage companies in the health care field. In establishing N-of-One, Dr. Carter brought to the enterprise extensive experience analyzing market opportunities, creating services to improve health care delivery, forming expert teams, and identifying business synergies. She also has experience in business analysis and planning for new technologies in health care. Prior to launching N-of-One, Dr. Carter was a consultant and analyzed biotechnology, pharmaceutical, and medical device firms on behalf of investors. She previously worked with Angel Healthcare Investors evaluating early-stage private companies and raising seed capital for start-ups.

Dr. Carter has B.S. degrees in Biochemistry and Biophysics from Yale University. She received an M.D. from Harvard Medical School and an M.P.H. from The Harvard School of Public Health.

About N-of-One N-of-One is dedicated to helping oncologists identify optimal personalized diagnostic and treatment strategies for each individual patient-each "n of one." Powered by our proprietary PrecisionWorks(TM) knowledge integration platform, the N-of-One team develops "roadmaps" that drive highly informed clinical decision-making by linking data about the molecular variations in each patient's cancer cells with leading-edge knowledge, diagnostics, treatments, and technologies relevant to the tumor type. PrecisionWorks(TM) also powers solutions that address the unique logistical and procedural challenges of delivering personalized cancer care by streamlining coordination among health care providers, diagnostic companies, payers, drug and technology innovators, and patients. N-of-One works with physicians and therefore does not provide medical advice nor promote any product or service. For more information, please visit


Copyright Business Wire 2012 PUB: 05/31/2012 09:00 AM/DISC: 05/31/2012 09:00 AM